映恩生物-B:人民币股份发行所得款项将用于创新药物研发等用途

美股速递
Apr 13

映恩生物-B宣布,其通过人民币股份发行筹集的资金,将主要用于支持公司创新药物的研发工作,以及其他相关业务发展。这一资金安排旨在进一步推动公司在生物医药领域的创新步伐,提升研发实力和市场竞争力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10